Works by Marabelle, Aurelien


Results: 53
    1

    Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications.

    Published in:
    OncoImmunology, 2015, v. 4, n. 4, p. 00, doi. 10.1080/2162402X.2015.1008814
    By:
    • Eggermont, Alexander;
    • Marabelle, Aurélien;
    • Zitvogel, Laurence;
    • Buqué, Aitziber;
    • Galluzzi, Lorenzo;
    • Bloy, Norma;
    • Castoldi, Francesca;
    • Tartour, Eric;
    • Kroemer, Guido;
    • Cremer, Isabelle;
    • Galon, Jérôme;
    • Fridman, Wolf Hervé;
    • Aranda, Fernando;
    • Spisek, Radek;
    • Fucikova, Jitka
    Publication type:
    Article
    2

    Trial watch: Tumor-targeting monoclonal antibodies for oncological indications.

    Published in:
    OncoImmunology, 2015, v. 4, n. 1, p. N.PAG, doi. 10.4161/2162402X.2014.985940
    By:
    • Eggermont, Alexander;
    • Vacchelli, Erika;
    • Pol, Jonathan;
    • Bloy, Norma;
    • Galluzzi, Lorenzo;
    • Marabelle, Aurélien;
    • Zitvogel, Laurence;
    • Kroemer, Guido;
    • Cremer, Isabelle;
    • Fridman, Wolf Hervé;
    • Galon, Jérôme;
    • Kohrt, Holbrook
    Publication type:
    Article
    3
    4

    Age Does not Affect the Efficacy of Antibody Drug Conjugates, But is Associated with High-Grade Adverse Events in Patients with Cancer Enrolled in Early Phase Clinical Trials.

    Published in:
    Drugs & Aging, 2025, v. 42, n. 6, p. 583, doi. 10.1007/s40266-025-01212-6
    By:
    • Vaz Ferreira, Ana;
    • Delaye, Matthieu;
    • Pages, Arnaud;
    • Hollebecque, Antoine;
    • Gazzah, Anas;
    • Bahleda, Rastio;
    • Michot, Jean-Marie;
    • Danlos, Francois-Xavier;
    • Seknazi, Lauren;
    • Goldschmidt, Vincent;
    • Hénon, Clémence;
    • Sakkal, Madonna;
    • Smolenschi, Cristina;
    • Champiat, Stéphane;
    • Marabelle, Aurelien;
    • Loriot, Yohann;
    • Nagera Lazarovici, Céline;
    • Ap-Thomas, Zoé;
    • Beraud Chaullet, Geoffroy;
    • Ponce Aix, Santiago
    Publication type:
    Article
    5

    Immune Checkpoint Inhibitor Use During Pregnancy and Outcomes in Pregnant Individuals and Newborns.

    Published in:
    JAMA Network Open, 2024, v. 7, n. 4, p. e245625, doi. 10.1001/jamanetworkopen.2024.5625
    By:
    • Gougis, Paul;
    • Hamy, Anne-Sophie;
    • Jochum, Floriane;
    • Bihan, Kevin;
    • Carbonnel, Marie;
    • Salem, Joe-Elie;
    • Dumas, Elise;
    • Kabirian, Rayan;
    • Grandal, Beatriz;
    • Barraud, Solenn;
    • Coussy, Florence;
    • Hotton, Judicael;
    • Savarino, Raphaelle;
    • Marabelle, Aurélien;
    • Cadranel, Jacques;
    • Spano, Jean-Philippe;
    • Laas, Enora;
    • Reyal, Fabien;
    • Abbar, Baptiste
    Publication type:
    Article
    6

    Renal toxicities associated with pembrolizumab.

    Published in:
    Clinical Kidney Journal, 2019, v. 12, n. 1, p. 81, doi. 10.1093/ckj/sfy100
    By:
    • Izzedine, Hassan;
    • Mathian, Alexis;
    • Champiat, Stephane;
    • Picard, Cécile;
    • Mateus, Christine;
    • Routier, Emilie;
    • Varga, Andrea;
    • Malka, David;
    • Leary, Alexandra;
    • Michels, Judith;
    • Michot, Jean-Marie;
    • Marabelle, Aurélien;
    • Lambotte, Olivier;
    • Amoura, Zahir;
    • Soria, Jean-Charles;
    • Kaaki, Sihem;
    • Quellard, Nathalie;
    • Goujon, Jean-Michel;
    • Brocheriou, Isabelle
    Publication type:
    Article
    7

    Patterns of progression in patients treated for immuno-oncology antibodies combination.

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 221, doi. 10.1007/s00262-020-02647-z
    By:
    • Bernard-Tessier, Alice;
    • Baldini, Capucine;
    • Castanon, Eduardo;
    • Martin, Patricia;
    • Champiat, Stéphane;
    • Hollebecque, Antoine;
    • Postel-Vinay, Sophie;
    • Varga, Andreea;
    • Bahleda, Rastilav;
    • Gazzah, Anas;
    • Michot, Jean-Marie;
    • Ribrag, Vincent;
    • Armand, Jean-Pierre;
    • Marabelle, Aurélien;
    • Soria, Jean-Charles;
    • Massard, Christophe;
    • Ammari, Samy
    Publication type:
    Article
    8
    9

    Clinical Characteristics and Outcome of Patients with Neuroblastoma Presenting Genomic Amplification of Loci Other than <i>MYCN</i>.

    Published in:
    PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0101990
    By:
    • Guimier, Anne;
    • Ferrand, Sandrine;
    • Pierron, Gaëlle;
    • Couturier, Jérôme;
    • Janoueix-Lerosey, Isabelle;
    • Combaret, Valérie;
    • Mosseri, Véronique;
    • Thebaud, Estelle;
    • Gambart, Marion;
    • Plantaz, Dominique;
    • Marabelle, Aurélien;
    • Coze, Carole;
    • Rialland, Xavier;
    • Fasola, Sylvie;
    • Lapouble, Eve;
    • Fréneaux, Paul;
    • Peuchmaur, Michel;
    • Michon, Jean;
    • Delattre, Olivier;
    • Schleiermacher, Gudrun
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17

    Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelae.

    Published in:
    Brain Communications, 2021, v. 3, n. 4, p. 1, doi. 10.1093/braincomms/fcab220
    By:
    • Plaçais, Léo;
    • Michot, Jean-Marie;
    • Champiat, Stéphane;
    • Romano-Martin, Patricia;
    • Baldini, Capucine;
    • Joao, Maria Silva;
    • Marabelle, Aurélien;
    • Voisin, Anne-Laure;
    • Not, Adeline;
    • Labeyrie, Céline;
    • Beaudonnet, Guillemette;
    • Laparra, Ariane;
    • Maria, Alexandre T. J.;
    • Masseau, Agathe;
    • Dehette, Stéphanie;
    • Deleporte, Amélie;
    • Echaniz-Laguna, Andoni;
    • Denier, Christian;
    • Adams, David;
    • Lambotte, Olivier
    Publication type:
    Article
    18

    Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell–mediated antitumor immune response.

    Published in:
    Science Translational Medicine, 2021, v. 13, n. 616, p. 1, doi. 10.1126/scitranslmed.abj0835
    By:
    • De Gassart, Aude;
    • Le, Kieu-Suong;
    • Brune, Patrick;
    • Agaugué, Sophie;
    • Sims, Jennifer;
    • Goubard, Armelle;
    • Castellano, Rémy;
    • Joalland, Noémie;
    • Scotet, Emmanuel;
    • Collette, Yves;
    • Valentin, Emmanuel;
    • Ghigo, Clement;
    • Pasero, Christine;
    • Colazet, Magali;
    • Guillén, Jaime;
    • Cano, Carla E.;
    • Marabelle, Aurélien;
    • De Bonno, Johann;
    • Hoet, René;
    • Truneh, Alemseged
    Publication type:
    Article
    19
    20

    Depleting tumor-specific Tregs at a single site eradicates disseminated tumors.

    Published in:
    Journal of Clinical Investigation, 2013, v. 123, n. 7, p. 2447, doi. 10.1172/JCI64859
    By:
    • Marabelle, Aurélien;
    • Kohrt, Holbrook;
    • Sagiv-Barfi, Idit;
    • Ajami, Bahareh;
    • Axtell, Robert C.;
    • Gang Zhou;
    • Rajapaksa, Ranjani;
    • Green, Michael R.;
    • Torchia, James;
    • Brody, Joshua;
    • Luong, Richard;
    • Rosenblum, Michael D.;
    • Steinman, Lawrence;
    • Levitsky, Hyam I.;
    • Tse, Victor;
    • Levy, Ronald
    Publication type:
    Article
    21
    22
    23

    Immunosenescence, inflammaging, and cancer immunotherapy efficacy.

    Published in:
    2022
    By:
    • Rodriguez, Julieta E;
    • Naigeon, Marie;
    • Goldschmidt, Vincent;
    • Roulleaux Dugage, Matthieu;
    • Seknazi, Lauren;
    • Danlos, Francois X;
    • Champiat, Stephane;
    • Marabelle, Aurélien;
    • Michot, Jean-Marie;
    • Massard, Christophe;
    • Besse, Benjamin;
    • Ferrara, Roberto;
    • Chaput, Nathalie;
    • Baldini, Capucine
    Publication type:
    Literature Review
    24

    <sup>18</sup>F-FDG PET and CT Scans Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti-Programmed Death 1 Immune Checkpoint Inhibitor.

    Published in:
    Journal of Nuclear Medicine, 2018, v. 59, n. 1, p. 15, doi. 10.2967/jnumed.117.193011
    By:
    • Dercle, Laurent;
    • Seban, Romain-David;
    • Lazarovici, Julien;
    • Schwartz, Lawrence H.;
    • Houot, Roch;
    • Ammari, Samy;
    • Danu, Alina;
    • Edeline, Véronique;
    • Marabelle, Aurélien;
    • Ribrag, Vincent;
    • Michot, Jean-Marie
    Publication type:
    Article
    25

    Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 10, p. 2301, doi. 10.1007/s00259-020-04757-3
    By:
    • Seban, Romain-David;
    • Moya-Plana, Antoine;
    • Antonios, Lara;
    • Yeh, Randy;
    • Marabelle, Aurélien;
    • Deutsch, Eric;
    • Schwartz, Lawrence H.;
    • Gómez, Ruth Gabriela Herrera;
    • Saenger, Yvonne;
    • Robert, Caroline;
    • Ammari, Samy;
    • Dercle, Laurent
    Publication type:
    Article
    26

    Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 11, p. 2298, doi. 10.1007/s00259-019-04411-7
    By:
    • Seban, Romain-David;
    • Nemer, John S.;
    • Marabelle, Aurélien;
    • Yeh, Randy;
    • Deutsch, Eric;
    • Ammari, Samy;
    • Moya-Plana, Antoine;
    • Mokrane, Fatima-Zohra;
    • Gartrell, Robyn D.;
    • Finkel, Grace;
    • Barker, Luke;
    • Bigorgne, Amélie E.;
    • Schwartz, Lawrence H.;
    • Saenger, Yvonne;
    • Robert, Caroline;
    • Dercle, Laurent
    Publication type:
    Article
    27
    28

    Predicting Immunotherapy Outcomes in Older Patients with Solid Tumors Using the LIPI Score.

    Published in:
    Cancers, 2022, v. 14, n. 20, p. 5078, doi. 10.3390/cancers14205078
    By:
    • Pierro, Monica;
    • Baldini, Capucine;
    • Auclin, Edouard;
    • Vincent, Hélène;
    • Varga, Andreea;
    • Martin Romano, Patricia;
    • Vuagnat, Perrine;
    • Besse, Benjamin;
    • Planchard, David;
    • Hollebecque, Antoine;
    • Champiat, Stéphane;
    • Marabelle, Aurélien;
    • Michot, Jean-Marie;
    • Massard, Christophe;
    • Mezquita, Laura
    Publication type:
    Article
    29

    CD8+ T Lymphocytes Immune Depletion and LAG-3 Overexpression in Hodgkin Lymphoma Tumor Microenvironment Exposed to Anti-PD-1 Immunotherapy.

    Published in:
    Cancers, 2021, v. 13, n. 21, p. 5487, doi. 10.3390/cancers13215487
    By:
    • Michot, Jean-Marie;
    • Mouraud, Severine;
    • Adam, Julien;
    • Lazarovici, Julien;
    • Bigenwald, Camille;
    • Rigaud, Charlotte;
    • Tselikas, Lambros;
    • Dartigues, Peggy;
    • Danu, Alina;
    • Bigorgne, Amélie;
    • Minard, Veronique;
    • Ghez, David;
    • Marabelle, Aurélien;
    • Zitvogel, Laurence;
    • Ribrag, Vincent
    Publication type:
    Article
    30

    Targeting CD137 enhances the efficacy of cetuximab.

    Published in:
    2019
    By:
    • Kohrt, Holbrook E;
    • Colevas, A Dimitrios;
    • Houot, Roch;
    • Weiskopf, Kipp;
    • Goldstein, Matthew J;
    • Lund, Peder;
    • Mueller, Antonia;
    • Sagiv-Barfi, Idit;
    • Marabelle, Aurelien;
    • Lira, Ruth;
    • Troutner, Emily;
    • Richards, Lori;
    • Rajapaska, Amanda;
    • Hebb, Jonathan;
    • Chester, Cariad;
    • Waller, Erin;
    • Ostashko, Anton;
    • Weng, Wen-Kai;
    • Chen, Lieping;
    • Czerwinski, Debra
    Publication type:
    corrected article
    31
    32

    Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma.

    Published in:
    2016
    By:
    • Jacquelot, Nicolas;
    • Enot, David P.;
    • Flament, Caroline;
    • Vimond, Nadège;
    • Blattner, Carolin;
    • Pitt, Jonathan M.;
    • Takahiro Yamazaki;
    • Roberti, María Paula;
    • Daillère, Romain;
    • Vétizou, Marie;
    • Poirier-Colame, Vichnou;
    • Semeraro, Michaëla;
    • Caignard, Anne;
    • Slingluff Jr., Craig L.;
    • Sallusto, Federica;
    • Rusakiewicz, Sylvie;
    • Weide, Benjamin;
    • Marabelle, Aurélien;
    • Kohrt, Holbrook;
    • Dalle, Stéphane
    Publication type:
    journal article
    33

    Targeting CD137 enhances the efficacy of cetuximab.

    Published in:
    Journal of Clinical Investigation, 2014, v. 124, n. 6, p. 2668, doi. 10.1172/JCI73014
    By:
    • Kohrt, Holbrook E.;
    • Colevas, A. Dimitrios;
    • Houot, Roch;
    • Weiskopf, Kipp;
    • Goldstein, Matthew J.;
    • Lund, Peder;
    • Mueller, Antonia;
    • Sagiv-Barfi, Idit;
    • Marabelle, Aurelien;
    • Lira, Ruth;
    • Troutner, Emily;
    • Richards, Lori;
    • Rajapaska, Amanda;
    • Hebb, Jonathan;
    • Chester, Cariad;
    • Waller, Erin;
    • Ostashko, Anton;
    • Wen-Kai Weng;
    • Lieping Chen;
    • Czerwinski, Debra
    Publication type:
    Article
    34
    35
    36
    37
    38
    39

    Exploring the Role of Target Expression in Treatment Efficacy of Antibody–Drug Conjugates (ADCs) in Solid Cancers: A Comprehensive Review.

    Published in:
    Current Oncology Reports, 2024, v. 26, n. 10, p. 1236, doi. 10.1007/s11912-024-01576-9
    By:
    • Mathiot, Laurent;
    • Baldini, Capucine;
    • Letissier, Octave;
    • Hollebecque, Antoine;
    • Bahleda, Rastislav;
    • Gazzah, Anas;
    • Smolenschi, Cristina;
    • Sakkal, Madona;
    • Danlos, François-Xavier;
    • Henon, Clémence;
    • Beshiri, Kristi;
    • Goldschmidt, Vincent;
    • Parisi, Claudia;
    • Patrikidou, Anna;
    • Michot, Jean-Marie;
    • Marabelle, Aurélien;
    • Postel-Vinay, Sophie;
    • Bernard-Tessier, Alice;
    • Loriot, Yohann;
    • Ponce, Santiago
    Publication type:
    Article
    40

    Intratumoral Immunotherapy: Is It Ready for Prime Time?

    Published in:
    Current Oncology Reports, 2023, v. 25, n. 8, p. 857, doi. 10.1007/s11912-023-01422-4
    By:
    • Ghosn, Mario;
    • Tselikas, Lambros;
    • Champiat, Stéphane;
    • Deschamps, Frederic;
    • Bonnet, Baptiste;
    • Carre, Émilie;
    • Testan, Marine;
    • Danlos, François-Xavier;
    • Farhane, Siham;
    • Susini, Sandrine;
    • Suzzoni, Steve;
    • Ammari, Samy;
    • Marabelle, Aurélien;
    • De Baere, Thierry
    Publication type:
    Article
    41
    42

    Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients.

    Published in:
    Science Translational Medicine, 2015, v. 7, n. 283, p. 1, doi. 10.1126/scitranslmed.aaa2327
    By:
    • Semeraro, Michaela;
    • Rusakiewicz, Sylvie;
    • Minard-Colin, Véronique;
    • Delahaye, Nicolas F.;
    • Enot, David;
    • Vély, Frédéric;
    • Marabelle, Aurélien;
    • Papoular, Benjamin;
    • Piperoglou, Christelle;
    • Ponzoni, Mirco;
    • Perri, Patrizia;
    • Tchirkov, Andrei;
    • Matta, Jessica;
    • Lapierre, Valérie;
    • Shekarian, Tala;
    • Valsesia-Wittmann, Sandrine;
    • Commo, Frédéric;
    • Prada, Nicole;
    • Poirier-Colame, Vichnou;
    • Bressac, Brigitte
    Publication type:
    Article
    43

    Delivering adapted physical activity by videoconference to patients with fatigue under immune checkpoint inhibitors: Lessons learned from the PACTIMe-FEAS feasibility study.

    Published in:
    Journal of Telemedicine & Telecare, 2023, v. 29, n. 9, p. 716, doi. 10.1177/1357633X211021743
    By:
    • Charles, Cécile;
    • Bardet, Aurélie;
    • Ibrahimi, Nusaïbah;
    • Aromatario, Olivier;
    • Cambon, Linda;
    • Imbert, Alexis;
    • Pons, Magali;
    • Raynard, Bruno;
    • Sauveplane, Dominique;
    • Pouchepadass, Camille;
    • Baudinet, Cédric;
    • Lambotte, Olivier;
    • Marabelle, Aurélien;
    • Dauchy, Sarah
    Publication type:
    Article
    44

    Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature.

    Published in:
    Transfusion, 2007, v. 47, n. 12, p. 2276, doi. 10.1111/j.1537-2995.2007.01469.x
    By:
    • Kanold, Justyna;
    • Merlin, Etienne;
    • Halle, Pascale;
    • Paillard, Catherine;
    • Marabelle, Aurelien;
    • Rapatel, Chantal;
    • Evrard, Bertrand;
    • Berger, Claire;
    • Stephan, Jean-Louis;
    • Galambrun, Claire;
    • Piguet, Christophe;
    • D'Incan, Michel;
    • Bordigoni, Pierre;
    • Deméocq, François
    Publication type:
    Article
    45
    46
    47
    48

    Long-term side effects of radiotherapy for pediatric localized neuroblastoma : results from clinical trials NB90 and NB94.

    Published in:
    2015
    By:
    • Ducassou, Anne;
    • Gambart, Marion;
    • Munzer, Caroline;
    • Padovani, Laetitia;
    • Carrie, Christian;
    • Haas-Kogan, Daphne;
    • Bernier-Chastagner, Valérie;
    • Demoor, Charlotte;
    • Claude, Line;
    • Helfre, Sylvie;
    • Bolle, Stéphanie;
    • Leseur, Julie;
    • Huchet, Aymeri;
    • Rubie, Hervé;
    • Valteau-Couanet, Dominique;
    • Schleiermacher, Gudrun;
    • Coze, Carole;
    • Defachelles, Anne-Sophie;
    • Marabelle, Aurélien;
    • Ducassou, Stéphane
    Publication type:
    journal article
    49

    Long-term side effects of radiotherapy for pediatric localized neuroblastoma.

    Published in:
    Strahlentherapie und Onkologie, 2015, v. 191, n. 7, p. 604, doi. 10.1007/s00066-015-0837-z
    By:
    • Ducassou, Anne;
    • Gambart, Marion;
    • Munzer, Caroline;
    • Padovani, Laetitia;
    • Carrie, Christian;
    • Haas-Kogan, Daphne;
    • Bernier-Chastagner, Valérie;
    • Demoor, Charlotte;
    • Claude, Line;
    • Helfre, Sylvie;
    • Bolle, Stéphanie;
    • Leseur, Julie;
    • Huchet, Aymeri;
    • Rubie, Hervé;
    • Valteau-Couanet, Dominique;
    • Schleiermacher, Gudrun;
    • Coze, Carole;
    • Defachelles, Anne-Sophie;
    • Marabelle, Aurélien;
    • Ducassou, Stéphane
    Publication type:
    Article
    50